Advances in COVID-19 and Cancer Research
Open Access
- 16 July 2024
- journal article
- editorial
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (14) , 4143
Abstract
The global health crisis caused by COVID-19 has radically changed the management of several diseasesKeywords
This publication has 20 references indexed in Scilit:
- Long-term effects of the COVID-19 pandemic for patients with cancerQuality of Life Research, 2024
- Stimuli-Responsive mRNA Vaccines to Induce Robust CD8+ T Cell Response via ROS-Mediated Innate Immunity BoostingJournal of the American Chemical Society, 2024
- Advancing mRNA Therapeutics: The Role and Future of Nanoparticle Delivery SystemsMolecular Pharmaceutics, 2024
- Correction: Evaluating the health and health economic impact of the COVID-19 pandemic on delayed cancer care in Belgium: A Markov model study protocolPLOS ONE, 2024
- A Targeted LC-MRM3 Proteomic Approach for the Diagnosis of SARS-CoV-2 Infection in Nasopharyngeal SwabsMolecular & Cellular Proteomics, 2024
- Performance characteristics of “lollipop” swabs for the diagnosis of infection with SARS-CoV-2Diagnostic Microbiology and Infectious Disease, 2024
- The Impact of Climate Change on Immunity and Gut Microbiota in the Development of DiseaseDiseases, 2024
- Performance Characteristics of “Lollipop” Swabs for the Diagnosis of Infection with SARS-CoV-2SSRN Electronic Journal, 2024
- Liver Injury in Patients Hospitalized for COVID-19: Possible Role of TherapyVaccines, 2022
- The Importance of Complying with Vaccination Protocols in Developed Countries: “Anti-Vax” Hysteria and the Spread of Severe Preventable DiseasesCurrent Medicinal Chemistry, 2019